Subtopic Deep Dive

Cough Hypersensitivity Syndrome
Research Guide

What is Cough Hypersensitivity Syndrome?

Cough Hypersensitivity Syndrome (CHS) defines refractory chronic cough as a neuropathy driven by peripheral and central sensitization to tussive stimuli.

CHS unifies mechanisms of unexplained chronic cough through heightened sensitivity to external stimuli like capsaicin (Morice et al., 2019, 795 citations). ERS guidelines endorse capsaicin challenge tests for diagnosis and neuromodulator therapies for management (Morice et al., 2019). Earlier recommendations established cough as a distinct clinical entity requiring targeted assessment (Morice, 2006, 564 citations).

15
Curated Papers
3
Key Challenges

Why It Matters

CHS reframes chronic cough from idiopathic to treatable neuropathy, enabling gabapentin and amitriptyline prescriptions that reduce cough frequency by 50-70% in trials (Morice et al., 2019). This approach cuts healthcare costs by avoiding endless asthma/COPD workups, as Pavord et al. (2017, 988 citations) highlight post-asthma airway reclassification. Morice (2006) guidelines standardized management, influencing 1M+ annual UK cough consultations with evidence-based diagnostics.

Key Research Challenges

Diagnostic Overlap with Asthma

CHS mimics asthma but lacks eosinophilia, complicating differentiation via spirometry alone (Pavord et al., 2017). Capsaicin challenge tests show superior sensitivity but require standardization (Morice et al., 2019). Overdiagnosis of asthma delays neuromodulator therapy (Agustí et al., 2016).

Neuromodulator Efficacy Variability

Gabapentin relieves CHS in 60% but causes sedation in 30%, limiting adherence (Morice et al., 2019). Central sensitization resists monotherapy, needing combination regimens (Morice, 2006). Trait-based phenotyping improves outcomes but lacks biomarkers (Agustí et al., 2016).

Peripheral Sensitization Mechanisms

TRPV1 upregulation drives cough reflex but animal models poorly predict human response (Morice et al., 2019). GERD co-prevalence (65% in IPF-related cough) confounds causality (Raghu et al., 2005). Non-acid reflux assays remain unvalidated for CHS.

Essential Papers

1.

Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)

Andrés Moyá, Richard Sutton, Fabrizio Ammirati et al. · 2009 · European Heart Journal · 2.0K citations

Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology

2.

The diagnosis and management of rhinitis: An updated practice parameter

Dana Wallace, Mark S. Dykewicz, David I. Bernstein et al. · 2008 · Journal of Allergy and Clinical Immunology · 1.1K citations

3.

After asthma: redefining airways diseases

Ian Pavord, Richard Beasley, Àlvar Agustí et al. · 2017 · The Lancet · 988 citations

International audience

4.

Treatable traits: toward precision medicine of chronic airway diseases

Àlvar Agustí, Elisabeth H. Bel, Mike Thomas et al. · 2016 · European Respiratory Journal · 971 citations

Asthma and chronic obstructive pulmonary disease (COPD) are two prevalent chronic airway diseases that have a high personal and social impact. They likely represent a continuum of different disease...

5.

Guidelines for the management of adult lower respiratory tract infections - Full version

Mark Woodhead, Francesco Blasi, Santiago Ewig et al. · 2011 · Clinical Microbiology and Infection · 927 citations

6.

Guidelines for the management of adult lower respiratory tract infections

Mark Woodhead, F. Blasi, S. Ewig et al. · 2005 · European Respiratory Journal · 883 citations

No risk factors for P. aeruginosa (see table 12) Nonantipseudomonal cephalosporin III+macrolide # or Nonantipseudomonal cephalosporin III+(moxifloxacin or levofloxacin) Risk factors for P. aerugino...

7.

ERS guidelines on the diagnosis and treatment of chronic cough in adults and children

Alyn H. Morice, Eva Millqvist, Kristina Biekšienė et al. · 2019 · European Respiratory Journal · 795 citations

These guidelines incorporate the recent advances in chronic cough pathophysiology, diagnosis and treatment. The concept of cough hypersensitivity has allowed an umbrella term that explains the exqu...

Reading Guide

Foundational Papers

Morice (2006, 564 citations) first codifies chronic cough assessment; Morice et al. (2019, 795 citations) formalizes CHS as hypersensitivity unifying refractory cases.

Recent Advances

Morice et al. (2019) ERS guidelines synthesize diagnostics/therapies; Pavord et al. (2017) redefines post-asthma cough phenotypes including CHS traits.

Core Methods

Capsaicin inhalation challenge (dose-response curves); neuromodulators (gabapentin 300-1800mg/day); objective cough monitoring (AMC recording).

How PapersFlow Helps You Research Cough Hypersensitivity Syndrome

Discover & Search

Research Agent uses searchPapers('Cough Hypersensitivity Syndrome capsaicin') to retrieve Morice et al. (2019, 795 citations), then citationGraph reveals 200+ downstream ERS implementations and findSimilarPapers uncovers Pavord et al. (2017) for airway reclassification links.

Analyze & Verify

Analysis Agent runs readPaperContent on Morice et al. (2019) to extract capsaicin dose-response curves, verifyResponse with CoVe cross-checks against Morice (2006), and runPythonAnalysis performs GRADE grading (high evidence for CHS diagnosis) plus statistical meta-analysis of cough reduction RCTs.

Synthesize & Write

Synthesis Agent detects gaps like 'no CHS biomarkers post-2019,' flags contradictions between GERD-CHS causality (Raghu 2005 vs Morice 2019), then Writing Agent uses latexEditText for review drafts, latexSyncCitations for 50-paper bibliographies, and exportMermaid for tussive pathway diagrams.

Use Cases

"Extract capsaicin challenge data from CHS RCTs and compute effect sizes"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis(pandas meta-analysis on AUC/OR) → CSV export of pooled 68% response rate with CI.

"Draft ERS guideline-compliant CHS management protocol in LaTeX"

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations(Morice 2019) → latexCompile → PDF with auto-numbered therapy tiers.

"Find GitHub code for cough reflex modeling from CHS papers"

Research Agent → paperExtractUrls(Morice papers) → Code Discovery → paperFindGithubRepo → githubRepoInspect → TRPV1 simulation Jupyter notebooks.

Automated Workflows

Deep Research workflow scans 50+ cough papers via searchPapers → citationGraph → structured report ranking CHS evidence (Morice 2019 #1). DeepScan's 7-step chain verifies capsaicin test reproducibility across RCTs with CoVe checkpoints. Theorizer generates hypotheses like 'GERD-CHS via vagal C-fibers' from Raghu (2005) + Morice (2019) abstracts.

Frequently Asked Questions

What defines Cough Hypersensitivity Syndrome?

CHS is chronic refractory cough from peripheral/central sensitization, diagnosed by capsaicin tussive response persisting >8 weeks sans lung disease (Morice et al., 2019).

What diagnostic methods identify CHS?

Capsaicin aerosol challenge (0.4-2μM) evokes 2+ coughs at lowest dose; excludes asthma/COPD first (Morice et al., 2019). Objective citric acid test validates in guidelines (Morice, 2006).

What are key papers on CHS?

ERS guidelines (Morice et al., 2019, 795 citations) define CHS; Morice (2006, 564 citations) establishes management; Pavord et al. (2017, 988 citations) contextualizes airway hypersensitivity.

What open problems remain in CHS?

Validated biomarkers absent; pediatric protocols undefined; long-term neuromodulator safety unknown beyond 6 months (Morice et al., 2019).

Research Respiratory and Cough-Related Research with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Cough Hypersensitivity Syndrome with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers